| Company Name: |
Guangzhou Isun Pharmaceutical Co., Ltd
|
| Tel: |
020-39119399 18927568969 |
| Email: |
isunpharm@qq.com |
| Products Intro: |
Product Name:L-Dopa ethyl ester
CAS:37178-37-3
Purity:98.0% Package:1g~500g
|
| Company Name: |
Sigma-Aldrich
|
| Tel: |
021-61415566 800-8193336 |
| Email: |
orderCN@merckgroup.com |
| Products Intro: |
Product Name:L-Dopa ethyl ester
CAS:37178-37-3
Purity:>=98% (HPLC) Package:5MG Remarks:SML0091-5MG
|
|
| | ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate Basic information |
| Product Name: | ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate | | Synonyms: | O-Ethyl-DOPA;TV-1203;ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate;L-DOPA Ethyl Ester;2(S)-Amino-3-(3,4-dihydroxyphenyl)propionic acid ethyl ester;3,4-Dihydroxy-L-phenylalanine ethyl ester;3-Hydroxy-L-tyrosine ethyl ester;L-Dopa-Et | | CAS: | 37178-37-3 | | MF: | C11H15NO4 | | MW: | 225.24 | | EINECS: | | | Product Categories: | | | Mol File: | 37178-37-3.mol |  |
| | ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate Chemical Properties |
| Boiling point | 394.2±37.0 °C(Predicted) | | density | 1.278±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | H2O: ≥12mg/mL at warmed to 60°C | | pka | 9.67±0.20(Predicted) | | form | powder | | color | white to tan |
| Hazard Codes | Xn | | Risk Statements | 22-36 | | Safety Statements | 26 | | WGK Germany | 3 |
| | ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate Usage And Synthesis |
| Uses | Antiparkisonian. | | Uses | L-Dopa ethyl ester has been used to study the protective effects of piperlongumine (PLG) on rotenone-induced Parkinson disease (PD). | | Definition | ChEBI: Etilevodopa is a tyrosine derivative. | | Biochem/physiol Actions | L-Dopa ethyl ester is a prodrug of levodopa that has greater gastric solubility. The drug is rapidly hydrolyzed to levodopa by nonspecific esterases in the gastrointestinal tract. L-Dopa ethyl ester (etilevodopa)-carbidopa treatment was well tolerated but did not demonstrate better efficacy compared with standard levodopa-carbidopa treatment. L-Dopa ethyl ester should have a significant brain penetration following an administration by injection. |
| | ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate Preparation Products And Raw materials |
|